Lithium intoxication associated with intramuscular ziprasidone in schizoaffective patients

Clinical Neuropharmacology

Volumn 28, Issue 6, 2005, Pages 295-297

  Miodownik, Chanoch ^a   Hausmann, Michael ^a   Frolova, Katherina ^a   Lerner, Vladimir ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MENTAL HEALTH CENTER   (Israel)

Author keywords

Combination therapy; Intoxication; Lithium; Parenteral injections; Ziprasidone

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; LITHIUM CARBONATE; NEUROLEPTIC AGENT; ZIPRASIDONE; LITHIUM; PIPERAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG INTOXICATION; HUMAN; KIDNEY FUNCTION; LABORATORY TEST; MALE; MANIC PSYCHOSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SYMPTOMATOLOGY; BIPOLAR DISORDER; BLOOD; BRIEF PSYCHIATRIC RATING SCALE; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; METHODOLOGY; PSYCHOMOTOR DISORDER; PSYCHOSIS;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BRIEF PSYCHIATRIC RATING SCALE; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; LITHIUM; MALE; PIPERAZINES; PSYCHOMOTOR DISORDERS; PSYCHOTIC DISORDERS; THIAZOLES;

EID: 33644873726     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnf.0000194037.75621.78     Document Type: Article

References (30)

1. Harvey NS, Merriman S. Review of clinically important drug interactions with lithium. Drug Saf. 1994;10:455-463.
2. Meyer MC, Baldessarini RJ, Goff DC, et al. Clinically significant interactions of psychotropic agents with antipsychotic drugs. Drug Saf. 1996;15:333-346.
3. Baastrup PC, Hollnagel P, Sorensen R, et al. Adverse reactions in treatment with lithium carbonate and haloperidol. JAMA. 1976;236:2645-2646.
4. Binder EF, Cayabyab L, Ritchie DJ, et al. Diltiazem-induced psychosis and a possible diltiazem-lithium interaction. Arch Intern Med. 1991;151:373-374.
5. Evans M, Marwick P. Fluvoxamine and lithium: an unusual interaction [letter]. Br J Psychiatry. 1990;156:286.
6. Normann C, Brandt C, Berger M, et al. Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction. Pharmacopsychiatry. 1998;31:201-204.
7. Slordal L, Samstad S, Bathen J, et al. A life-threatening interaction between lithium and celecoxib [letter]. Br J Clin Pharmacol. 2003;55:413-414.
8. MacDonald J, Neale TJ. Toxic interaction of lithium carbonate and mefenamic acid [letter]. BMJ. 1988;297:1339.
9. Noveske FG, Hahn KR, Flynn RJ. Possible toxicity of combined fluoxetine and lithium [letter]. Am J Psychiatry. 1989;146:1515.
10. Salama AA, Shafey M. A case of severe lithium toxicity induced by combined fluoxetine and lithium carbonate [letter]. Am J Psychiatry. 1989;146:278.
11. Austin LS, Arana GW, Melvin JA. Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients. J Clin Psychiatry. 1990;51:344-345.
12. Thornton WE, Pray BJ. Lithium intoxication: a report of two cases. Can Psychiatr Assoc J. 1975;20:281-282.
13. Alevizos B. Toxic reactions to lithium and neuroleptics [letter]. Br J Psychiatry. 1979;135:482.
14. Spring G, Frankel M. New data on lithium and haloperidol incompatibility. Am J Psychiatry. 1981;138:818-821.
15. Marhold J, Zimanova J, Lachman M, et al. To the incompatibility of haloperidol with lithium salts. Act Nerv Super (Praha). 1974;16:199-200.
16. Prakash R, Kelwala S, Ban TA. Neurotoxicity with combined administration of lithium and a neuroleptic. Compr Psychiatry. 1982;23:567-571.
17. Blake LM, Marks RC, Luchins DJ. Reversible neurologic symptoms with clozapine and lithium. J Clin Psychopharmacol. 1992;12:297-299.
18. Swanson CL Jr, PriceWA, McEvoy JP. Effects of concomitant risperidone and lithium treatment [letter]. Am J Psychiatry. 1995;152:1096.
19. Apseloff G, Mullet D, Wilner KD, et al. The effects of ziprasidone on steady-state lithium levels and renal clearance of lithium. Br J Clin Pharmacol. 2000;49(suppl 1):61-64.
20. Finley PR, Warner MD, Peabody CA. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet. 1995;29:172-191.
21. Marcus WL. Lithium: a reviewof its pharmacokinetics, health effects, and toxicology. J Environ Pathol Toxicol Oncol. 1994;13:73-79.
22. Pandey GN, Goel I, Davis JM. Effect of neuroleptic drugs on lithium uptake by the human erythrocyte. Clin Pharmacol Ther. 1979;26:96-102.
23. von Knorring L, Smigan L, Perris C, et al. Lithium and neuroleptic drugs in combination - effect on lithium RBC/plasma ratio. Int Pharmacopsychiatry. 1982;17:287-292.
24. Kessel JB, Verghese C, Simpson GM. Neurotoxicity related to lithium and neuroleptic combinations? A retrospective review. J Psychiatry Neurosci. 1992;17:28-30.
25. Deleted in press.
26. Freeman MP, Stoll AL. Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry. 1998;155:12-21.
27. Loudon JB, Waring H. Toxic reactions to lithium and haloperidol [letter]. Lancet. 1976;2:1088.
28. Marcoux AW. Carbamazepine-lithium drug interaction [letter]. Ann Pharmacother. 1996;30:547.
29. Price WA, Giannini AJ. Neurotoxicity caused by lithium-verapamil synergism. J Clin Pharmacol. 1986;26:717-719.
30. Raskin DE. Lithium and phenytoin interaction [letter]. J Clin Psychopharmacol. 1984;4:120.